Official Statistics

Mefloquine (Lariam) prescribing in the UK Armed Forces: 12 September 2016 to 31 March 2022

This statistical bulletin presents a summary of mefloquine prescribing following the introduction of a new policy in September 2016.

• From: Ministry of Defence
• Published: 26 May 2022

Documents

Mefloquine (Lariam) prescribing in the UK Armed Forces: 12 September 2016 to 31 March 2022

HTML

Background Quality Report Mefloquine Prescribing in the UK Armed Forces

HTML

Mefloquine Prescribing in the UK Armed Forces Supplementary tables - O

ODS, 82.6 KB

This file is in an OpenDocument format

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Mefloquine Prescribing in the UK Armed Forces Supplementary tables - O

MS Excel Spreadsheet, 105 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Mefloquine (also known as Lariam) is used to prevent or treat malaria. It may be prescribed as one of a number of alternative chemoprophylactic drugs for military personnel deployed to areas where there is a high risk of chloroquine resistant malaria. This biannual official statistic provides information on the number of mefloquine prescriptions given to UK armed forces personnel at MOD medical facilities covering the period 12 September 2016 to 31 March 2022.

Published 26 May 2022